JeremyAFalkMD
Pulmonology • Los Angeles, CACritical Care Medicine, Interstitial Lung Diseases, Lung Transplantation Medicine, Pulmonary Vascular Medicine
Acting Division Director Fellowship program director, pulmonary and critical care Cedars-Sinai Medical Center
Dr. Falk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8900 Beverly Blvd
Los Angeles, CA 90048Phone+1 310-423-5000Fax+1 310-423-0120
Education & Training
Temple University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005- Temple University HospitalChief Residency, Internal Medicine, 2001 - 2002
- Temple University HospitalResidency, Internal Medicine, 1998 - 2001
Ohio State University College of MedicineClass of 1998, MD
Certifications & Licensure
CA State Medical License 2005 - 2027
PA State Medical License 1999 - 2006- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- ABSMSleep Medicine
Publications & Presentations
PubMed
- Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related inter...Sangmee Sharon Bae, Fereidoun Abtin, Grace Kim, Daniela Markovic, Cato Chan
RMD Open. 2024-11-27 - Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung disease.Sangmee Sharon Bae, Daniela Markovic, Didem Saygin, Daniel Sullivan, Koichi Yamaguchi
Rheumatology. 2024-09-02 - 4 citationsPembrolizumab-Induced Diabetic Ketoacidosis: A Review of Critical Care CaseKeerthana Sankar, Matthew Macfarlane, Odelia Cooper, Jeremy A. Falk
Cureus. 2021-10-01
Press Mentions
Study Finds Hydroxychloroquine Has No Benefit for Treating COVID-19April 22nd, 2020
Coronavirus: Malaria Drug Pushed by Trump as COVID-19 Cure Has No Benefit, Research FindsApril 22nd, 2020
Idiopathic Pulmonary Fibrosis: Promising Drug Therapies for Fatal Lung Disease FoundMay 19th, 2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
